Edmonton, AB – December 22, 2025 – PRESSADVANTAGE – A first in western Canada, access to TIER-1 ENDOSURE testing for the ...

Sense of smell in patients with head and neck cancer began to deteriorate at a radiation dose of 22 Gy and increased in a ...

Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.

Cui, J.X., Liu, K.H. and Liang, X.J. (2026) A Brief Discussion on the Theory and Application of Artificial Intelligence in ...

numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON (R) LDLp Test System -- AXINON (R) LDLp Test System receives Medical Device Authority (MDA) in ...

Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA® home sleep apnea test.

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

Florian Voss, Chief Executive Officer at numares Health said: "Malaysia is a known leader in innovation in the ASEAN region and their swift approval and adoption of the AXINON® LDLp Test System ...

A model that combines a host biomarker with a generative artificial intelligence (AI) analysis of electronic medical records ...

The company has developed a method to detect circulating tumor DNA in surgical drain fluid from postoperative patients to detect molecular residual disease.

A self-referral tool for patients with chronic back pain may be a feasible solution for identifying axial spondyloarthritis, ...

The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...